Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
Ying Wang,Xiangyu Pan,Junwei Wang,Haixu Chen,Lan Chen
DOI: https://doi.org/10.1097/md.0000000000035193
IF: 1.6
2023-10-07
Medicine
Abstract:Knee osteoarthritis (KOA) is the most common joint inflammatory disease in orthopedics. The main feature is the gradual degeneration and loss of articular cartilage, accompanied by changes in joint structure and function. [ 1 ] After entering the 21st century, because of the increase in life expectancy and increase in body mass index due to the increase of population of old people, the prevalence of KOA has increased significantly and tended to be younger. [ 2 ] Currently, KOA accounts for 85% of the global burden of osteoarthritis, and the incidence of symptomatic KOA is 8.1%. [ 3 ] The main clinical manifestations of KOA are inconvenient movement of the limbs, difficulty in moving, and pain and swelling around the joints, which are more obvious after waking up in the morning, and can lead to paralysis in severe cases in the later stage. [ 2 ] Inflammation is the most common cause of joint pain and patient disability, and no effective treatment has been found to delay the progression of KOA, so most patients will undergo total joint replacement to relieve symptoms and improve physical performance, but it is expensive and traumatic large, slow recovery in the later period. [ 4–6 ] Therefore, it is crucial to understand the pathogenic process of KOA and the cellular and molecular mechanisms involved. The current process of osteoarthritis of the knee contains 2 basic aspects: the action of different joint elements and posttraumatic osteoarthritis formation. [ 7 , 8 ] On one hand, in nontraumatic circumstances, the development of knee osteoarthritis is a degenerative pathology associated with aging. Injuries to the components of the knee joint, such as synovitis, ligament, meniscus, free bodies, popliteal cysts, and chondromalacia of the patella, can also result in the development of knee osteoarthritis. In addition, knee osteoarthritis can be brought on by putting on too much weight, adopting bad gait patterns, squatting for extended periods of time, and exposing the knee joint to the cold. [ 4 , 9 ] On the other hand, posttraumatic osteoarthritis development, a progressive form of arthritis in the knee following trauma, is a significant contributor to osteoarthritis of the knee. It has clinical symptoms with osteoarthritis, but it also has a clear history of trauma, such as transarticular fractures. [ 10 , 11 ] At present, the most common manifestation of KOA is pain, and the effective drugs for pain relief are nonsteroidal antiinflammatory drugs. [ 12 ] However, such drugs are only suitable for short-term pain relief, and cannot control the wear and tear of articular cartilage, and cannot solve the fundamental problem. [ 13 ] Moreover, such drugs may cause gastrointestinal discomfort such as nausea and vomiting, and increase the risk of gastrointestinal bleeding. [ 14 ] Therefore, it is imperative to develop a drug that can maintain the curative effect of the drug and reduce side effects as much as possible.
medicine, general & internal